rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2009-2-3
|
pubmed:abstractText |
Atopic dermatitis (AD) is most prevalent in areas of reduced skin barrier reserve, like face and neck, especially in children. Treatment with topical corticosteroids (TCS) is limited due to heightened risk of treatment-associated side-effects, thus necessitating alternative AD therapies.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1365-2133
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
160
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
415-22
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:19067708-Adrenal Cortex Hormones,
pubmed-meshheading:19067708-Child,
pubmed-meshheading:19067708-Child, Preschool,
pubmed-meshheading:19067708-Dermatitis, Atopic,
pubmed-meshheading:19067708-Dermatologic Agents,
pubmed-meshheading:19067708-Double-Blind Method,
pubmed-meshheading:19067708-Eczema,
pubmed-meshheading:19067708-Facial Dermatoses,
pubmed-meshheading:19067708-Female,
pubmed-meshheading:19067708-Humans,
pubmed-meshheading:19067708-Male,
pubmed-meshheading:19067708-Pharmaceutical Vehicles,
pubmed-meshheading:19067708-Pruritus,
pubmed-meshheading:19067708-Severity of Illness Index,
pubmed-meshheading:19067708-Tacrolimus,
pubmed-meshheading:19067708-Treatment Outcome
|
pubmed:year |
2009
|
pubmed:articleTitle |
The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
|
pubmed:affiliation |
Department of Paediatric Dermatology, Catholic Children's Hospital, Wilhelmstift, Liliencronstr. 130, 22149 Hamburg, Germany. p.hoeger@kkh-wilhelmstift.de
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|